Rho-Kinases Inhibitors

 
Cat.No.
Product Name / Activity
4927 AS 1892802
Potent ROCK inhibitor; orally bioavailable
0541 Fasudil hydrochloride
Inhibitor of cyclic nucleotide dependent- and Rho-kinases
4009 GSK 269962
Potent and selective ROCK inhibitor
3726 GSK 429286
Selective Rho-kinase (ROCK) inhibitor
2414 H 1152 dihydrochloride
Selective Rho-kinase (ROCK) inhibitor
2485 Glycyl-H 1152 dihydrochloride
Selective Rho-kinase (ROCK) inhibitor. More selective analog of H 1152 dihydrochloride (Cat. No. 2414)
2415 HA 1100 hydrochloride
Cell-permeable, selective Rho-kinase inhibitor
5182 OXA 06 dihydrochloride
Potent ROCK inhibitor
5061 RKI 1447 dihydrochloride
Potent and selective ROCK inhibitor; antitumor
4118 SB 772077B dihydrochloride
Potent Rho-kinase inhibitor; vasodilator
3667 SR 3677 dihydrochloride
Potent, selective Rho-kinase (ROCK) inhibitor
4961 TC-S 7001
Potent and highly selective ROCK inhibitor; orally active
1254 Y-27632 dihydrochloride
Selective p160ROCK inhibitor

View all Rho-Kinases products

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Kinase Inhibitor Toolbox

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

Kinases Product Listing

Kinases Product Listing

Our Kinase listing highlights over 400 products for kinase research. Request copy or view PDF today.

divider line

Cardiovascular Research Product Guide

Cardiovascular Research Product Guide

Our Cardiovascular Guide highlights over 250 products for cardiovascular research. Request copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Life Science Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance. Request copy today.

divider line

Twitter Updates

Follow @Tocris on Twitter

Follow us on Twitter!

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.